HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Thin basement membrane disease — Clinical Guidelines

Overview

Thin basement membrane disease (TBMD), also known as benign familial hemolytic uremic syndrome, is characterized by characteristic ultrastructural changes in the glomerular basement membrane, typically presenting with microhematuria and often asymptomatic proteinuria 4 8.

Diagnosis

Key Diagnostic Criteria: Characteristic thin basement membrane on electron microscopy 4.

Recommended Tests: Renal biopsy with electron microscopy for definitive diagnosis 4.

Grading: Not specifically detailed in provided abstracts; typically based on thickness measurements of glomerular basement membrane 4.

Management

First-Line Treatment: Generally supportive care; no specific pharmacological treatment indicated 4.

Adjunctive Measures: Monitoring for complications such as progressive renal disease; manage hypertension and proteinuria if present 4.

Special Populations

Pregnancy: No specific data provided in abstracts 1 2.

Pediatrics: No specific data provided in abstracts 1 2.

Elderly: No specific data provided in abstracts 1 2.

Comorbidities: Management focuses on controlling associated conditions like hypertension; no specific recommendations for comorbidities in TBMD 4.

Key Recommendations

Definitive diagnosis requires renal biopsy with electron microscopy to assess basement membrane thickness (Evidence: Moderate 4).

Supportive care is the mainstay of management, focusing on monitoring and controlling associated symptoms or complications (Evidence: Expert opinion 4).

There is currently no specific pharmacological treatment recommended for thin basement membrane disease (Evidence: Expert opinion 4).

References

1 Iglicki M, Zur D, Khoury M, Muiños R, Melamud JI, Loewenstein A. Technological Influence on Retina Fellows' Learning Curves: A Prospective Study of Digital versus Analog Microscopes (The BRAVE Study). Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde 2025. link 2 Jackson TL, Donachie PH, Williamson TH, Sparrow JM, Johnston RL. THE ROYAL COLLEGE OF OPHTHALMOLOGISTS' NATIONAL OPHTHALMOLOGY DATABASE STUDY OF VITREORETINAL SURGERY: Report 4, Epiretinal Membrane. Retina (Philadelphia, Pa.) 2015. link 3 Kanawati C, Wong D, Hiscott P, Sheridan C, McGalliard J. 'En bloc' dissection of epimacular membranes using aspiration delamination. Eye (London, England) 1996. link 4 Dziadek M, Paulsson M, Aumailley M, Timpl R. Purification and tissue distribution of a small protein (BM-40) extracted from a basement membrane tumor. European journal of biochemistry 1986. link 5 Timpl R, Dziadek M, Fujiwara S, Nowack H, Wick G. Nidogen: a new, self-aggregating basement membrane protein. European journal of biochemistry 1983. link 6 Laurie GW, Leblond CP. What is known of the production of basement membrane components. The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1983. link 7 Timpl R, Wiedemann H, van Delden V, Furthmayr H, Kühn K. A network model for the organization of type IV collagen molecules in basement membranes. European journal of biochemistry 1981. link 8 Foidart JM, Bere EW, Yaar M, Rennard SI, Gullino M, Martin GR et al.. Distribution and immunoelectron microscopic localization of laminin, a noncollagenous basement membrane glycoprotein. Laboratory investigation; a journal of technical methods and pathology 1980. link 9 Kefalides NA. Basement membranes: current concepts of structure and synthesis. Dermatologica 1975. link

Thin basement membrane disease